ECMC participating in AstraZeneca Clinical Trial Studies to Treat Head & Neck Cancer Patients with Newest Investigational Product
Dec 11, 2015 / News & Media
The Center for Oncology Care Department of Head & Neck and Plastic & Reconstructive Surgery and Medical Oncology at ECMC (Erie County Medical Center) was selected by AstraZeneca to be among the first cancer treatment providers in the nation to take part in a clinical trial with the AstraZeneca investigational product durvalumab (MEDI4736).